Source:
The entry of new contraceptive implants and the exit of Norplant leaves family planning programs to decide whether to add one of the new implants to their method mix and if so, which one to introduce—Jadelle, Implanon, or Sino-implant (II). Programs evaluate a variety of factors in deciding which implant to introduce. This brief discusses these factors, including regulatory approval, cost, and service delivery issues.
This resource is extracted from the Population Reports issue, "Implants: The Next Generation". (For the French version, see "Implants: La Génération Suivante."
- Regions/Countries:
- Global
Quick Links
Long-Acting and Permanent Methods (LA/PMs)
Register for the e-conference on long-acting and permanent methods. Hosted by the SHOPS project, the conference will be held on May 8-10, 2012, and will discuss lessons learned about the private-sector provision of these methods.
The information provided on this website is not official U.S. Government information and does not represent the views or position
of the U.S. Agency for International Development, the U.S. Government, or The Johns Hopkins University. Read our full Security & Privacy Policies.